CD34 and colorectal carcinoma: ECM receptor interaction, glycosaminoglycan biosynthesis chondroitin sulfate, and cell adhesion molecules (CAMs) signaling pathways may be the potential mechanisms of CD34/CD276 promoting immune escape of CRC.